Literature DB >> 28878923

A 31-year-old with idiopathic reversible cerebral vasoconstriction syndrome.

Ihtesham A Qureshi1, Mohtashim A Qureshi1, Obiajulu Kanu2, Salvador Cruz-Flores1.   

Abstract

In our patient with reversible cerebral vasoconstriction syndrome (RCVS) syndrome, presenting with thunderclap-like headache, there is a possibility to be readily confused with migraine. Initiating treatment with selective serotonin reuptake inhibitors (SSRIs) and triptans can further aggravate the condition. Therefore, it is essential to understand the nature and type of headache and correlate the clinical findings with imaging studies.

Entities:  

Keywords:  Cerebral angiogram; migraine; reversible cerebral vasoconstriction syndrome; thunderclap headache

Year:  2017        PMID: 28878923      PMCID: PMC5582242          DOI: 10.1002/ccr3.1090

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


A 31‐year‐old female presented with severe headache that started a week ago not relieved on pain medications, comes to the hospital with severe headache, intermittent, pulsatile, throbbing type, located over the frontal region bilaterally radiating to the back of the head associated with three episodes of non‐bloody, non‐bilious vomiting. Computed tomography (CT) of head without contrast, lumbar puncture, and CT angiogram head were negative (Figs 1 and 2). Secondary causes for reversible cerebral vasoconstriction syndrome (RCVS) like subarachnoid hemorrhage (SAH) were ruled out from negative computed tomography head (CT) and lumbar puncture (LP), while vasculitis was excluded from the laboratory findings that showed normal erythrocyte sedimentation rate (ESR), anti‐nuclear antibody (ANA), anti‐neutrophil cytoplasmic antibody (ANCA) P&C, cryoglobulin, complement, rheumatoid factor (RF), anti SS‐A and SS‐B levels along with unremarkable cerebrospinal fluid analysis (CSF). The patient was started on sertraline and sumatriptan with no relief. Neurology was consulted to evaluate the headache. They recommended to stop both medications and initiate with magnesium, solumedrol, and verapamil 1, 2. Cerebral angiogram was performed and demonstrated the imaging stigmata of RCVS (Fig. 3A and B). Patient's headache improved and was discharged on verapamil with follow up within 4–6 weeks.
Figure 1

Computed tomography (CT) head and brain without contrast is negative for acute intracranial pathology.

Figure 2

Computed tomography (CT) angiogram with IV contrast was negative for acute intracranial abnormalities, intra‐cranial arterial flow limiting stenosis, aneurysms, dissections, occlusion, or vascular malformations.

Figure 3

(A) Cerebral angiogram shows multiple areas of arterial constriction in the anterior and posterior circulations findings consistent with reversible cerebral vasoconstriction syndrome. (B) Cerebral angiogram shows multiple areas of arterial constriction in the anterior and posterior circulations findings consistent with reversible cerebral vasoconstriction syndrome.

Computed tomography (CT) head and brain without contrast is negative for acute intracranial pathology. Computed tomography (CT) angiogram with IV contrast was negative for acute intracranial abnormalities, intra‐cranial arterial flow limiting stenosis, aneurysms, dissections, occlusion, or vascular malformations. (A) Cerebral angiogram shows multiple areas of arterial constriction in the anterior and posterior circulations findings consistent with reversible cerebral vasoconstriction syndrome. (B) Cerebral angiogram shows multiple areas of arterial constriction in the anterior and posterior circulations findings consistent with reversible cerebral vasoconstriction syndrome.

Conflict of Interest

None declared.

Authorship

IAQ: involved in manuscript writing; MAQ: involved in critical revision of the manuscript; OK and SCF: involved in patient care.
  2 in total

1.  Exertional reversible cerebral vasoconstriction responsive to verapamil.

Authors:  Brett J Theeler; Michael V Krasnokutsky; Beverly R Scott
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

Review 2.  Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.

Authors:  Yuji Kato; Takeshi Hayashi; Satoko Mizuno; Yohsuke Horiuchi; Masayuki Ohira; Norio Tanahashi; Masaki Takao
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.